Insight Inv LLC Laboratory Corp Of America Holdings Transaction History

Insight Inv LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$209.01 - $232.56 $47,027 - $52,326	-225 Reduced 6.06%	3,485 $761,000
Q2 2023 Aug 08, 2023	SELL	$211.93 - $241.33 $62,519 - $71,192	-295 Reduced 7.37%	3,710 $895,000
Q1 2023 May 12, 2023	SELL	$213.32 - $257.83 $66,129 - $79,927	-310 Reduced 7.18%	4,005 $918,000
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $34,632 - $42,324	170 Added 4.1%	4,315 $1.02 Million
Q3 2022 Nov 09, 2022	BUY	$204.81 - $262.19 $33,793 - $43,261	165 Added 4.15%	4,145 $849,000
Q1 2022 May 10, 2022	SELL	$259.82 - $298.18 $88,598 - $101,679	-341 Reduced 7.89%	3,980 $1.05 Million
Q4 2021 May 09, 2022	BUY	$271.6 - $314.21 $1.17 Million - $1.36 Million	4,321 New	4,321 $1.36 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Insight Inv LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Inv LLC with notifications on news.